Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. Claims & Support/References for Claims
  4. Patient case studies
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

Patient case studies

Scheduled Pinned Locked Moved Claims & Support/References for Claims
4 Posts 2 Posters 579 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • C Offline
    C Offline
    charlton
    wrote on last edited by
    #1

    Are real patient case studies, used to illustrate before and after effects, which were not taken from the efficacy studies in the PM, acceptable in a branded piece?

    Jennifer CarrollJ 1 Reply Last reply
    0
    • C charlton

      Are real patient case studies, used to illustrate before and after effects, which were not taken from the efficacy studies in the PM, acceptable in a branded piece?

      Jennifer CarrollJ Offline
      Jennifer CarrollJ Offline
      Jennifer Carroll
      wrote on last edited by
      #2

      Hello @charlton

      A real patient case can be used when it can be supported by statistically significant pre-defined endpoints from a randomized control trial (RCT) (s3.1.3). The outcomes discussed should be consistent with the outcomes from the trial and within the limitations of the TMA (PM). Effects which are not directly supported by statistically significant data from a RCT, would not be acceptable. The patient case would be required to be disclaimed to be clear and complete.

      1 Reply Last reply
      0
      • C Offline
        C Offline
        charlton
        wrote on last edited by
        #3

        Thanks for your reply. However, I'm still not clear about whether the patient is required to have been one of the patients included in the trial included in the PM.

        Jennifer CarrollJ 1 Reply Last reply
        0
        • C charlton

          Thanks for your reply. However, I'm still not clear about whether the patient is required to have been one of the patients included in the trial included in the PM.

          Jennifer CarrollJ Offline
          Jennifer CarrollJ Offline
          Jennifer Carroll
          wrote on last edited by
          #4

          Hey @charlton

          No, a patient case is not required to be on a patient who actually participated in the PM trial.

          1 Reply Last reply
          0
          Reply
          • Reply as topic
          Log in to reply
          • Oldest to Newest
          • Newest to Oldest
          • Most Votes


          • Login

          • Don't have an account? Register

          • Login or register to search.
          • First post
            Last post
          0
          • Categories
          • Recent
          • Tags
          • Popular
          • Users
          • Groups